Group B Streptococcal Infections

While Group B Streptococcus (GBS) is well-known for its impact on maternal and neonatal health, it can also cause invasive infections in non-pregnant adults, particularly those with underlying health conditions or compromised immune systems. Invasive GBS infections in adults often manifest as bacteremia, soft tissue infections, urinary tract infections, or bone and joint infections. Certain populations, such as older adults and individuals with chronic medical conditions, are at an increased risk of GBS invasive disease. Factors such as diabetes, cancer, and immunosuppressive therapy can contribute to susceptibility to GBS infections. The clinical presentation can vary, ranging from localized infections to more severe systemic manifestations. Diagnosis of invasive GBS infections involves blood or tissue cultures to identify the presence of the bacterium. Antibiotic therapy, typically with beta-lactam antibiotics such as penicillin or ceftriaxone, is the mainstay of treatment. Early recognition and prompt intervention are crucial to improve outcomes, especially in cases of severe invasive disease. Preventive measures for invasive GBS infections in non-pregnant adults involve addressing underlying health conditions, promoting general hygiene practices, and implementing infection control measures in healthcare settings. Vaccines targeting GBS are also under investigation for their potential to prevent invasive disease in various populations. As research advances, a comprehensive understanding of GBS infections in both pregnant and non-pregnant individuals contributes to improved clinical management and prevention strategies.